RA Capital Healthcare Fund LP's Form 4 filing
Climb Bio, Inc. (CLYM) · filed Jul 1, 2024
- Accession no.
- 0001415889-24-018708
- Filed
- Jul 1, 2024, 9:29 PM ET
- Trade date
- Jun 27, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $50.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | Director, 10% Owner |
| Ra Capital Management, L.P.CIK 0001346824 | Director, 10% Owner |
| Kolchinsky PeterCIK 0001384859 | Director, 10% Owner |
| Shah Rajeev M.CIK 0001619841 | Director, 10% Owner |
| RA Capital Nexus Fund, L.P.CIK 0001780117 | Director |
| RA Capital Nexus Fund II, L.P.CIK 0001825376 | Director |
| RA Capital Nexus Fund III, L.P.CIK 0001883840 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2024 | Common Stock | AGrant or awardAcquired | +973,000 | – | – | 11,572,586 | Indirect | |
| Jun 27, 2024 | Common Stock | AGrant or awardAcquired | +2,479,872 | – | – | 2,479,872 | Indirect | |
| Jun 27, 2024 | Common Stock | AGrant or awardAcquired | +1,807,000 | – | – | 1,807,000 | Indirect | |
| Jun 27, 2024 | Common Stock | PPurchaseAcquired | +11,949,171 | $3.84 | +$45,884,816.64 | 23,521,757 | Indirect | |
| Jun 27, 2024 | Common Stock | PPurchaseAcquired | +1,059,375 | $3.84 | +$4,068,000 | 2,866,375 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.